Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose ticagrelor vs clopidogrel in prior myocardial infarction: randomized pharmacodynamic crossover trial
2016-000880-18Phase 2Completed
- Sponsor
- University of Patras
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ticagrelor and clopidogrel in myocardial infarction (MI) and coronary arteriosclerosis (2 arms), sponsored by University of Patras. Primary endpoint: Platelet reactivity (PRU) pre- and post-crossover. Started Jun 2016; status: completed.
02
Drugs
ticagrelorclopidogrel
03
Conditions
myocardial infarction (MI)coronary arteriosclerosis
Beyond the preview
Go deeper on 2016-000880-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000880-18.